Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-05-03FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for the fixed-dose combination of bisoprolol fumarate and hydrochlorothiazide. This action updates t…
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension [Phase 4]
A Phase 4 trial comparing valsartan with amlodipine in postmenopausal women with hypertension has completed and posted results evaluating ef…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: 8 Weeks Study to Evaluate the Efficacy and Safety of Valsartan in Combination With Aliskiren Compared to Valsartan Alone in Patients With Stage 2 Hypertension [Phase 4]
Phase 4 trial comparing valsartan combined with aliskiren versus valsartan alone in Stage 2 Hypertension to assess efficacy and safety; resu…
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: CKD-828 (40/5mg) Pharmacokinetic Study [Phase 1]
A Phase 1 pharmacokinetic study of CKD-828 at 40/5 mg has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-28Clinical Trial Update: Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease [Phase 2]
A Phase 2 clinical trial investigated the effect of intradialytic vasopressin on chronic hypertension in patients with end-stage renal disea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy [Phase 3]
Phase 3 trial comparing valsartan plus amlodipine versus losartan plus hydrochlorothiazide in hypertensive patients with left ventricular hy…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic Hypertension [Phase 4]
Phase 4 clinical trial comparing aliskiren/amlodipine/hydrochlorothiazide versus aliskiren/amlodipine in US minority patients with stage II …
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: CKD-828 Primary Hypertension Trial(Dose-selection) [Phase 2]
Phase 2 dose-selection trial of CKD-828 for hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety of adding nebivolol to lisinopril or losartan in hypertensive patients; results posted in 2…
-
FDA approval · 2011-04-21FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for MATZIM LA (diltiazem hydrochloride) by Actavis Pharma, Inc.
-
FDA approval · 2011-04-20FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s quinapril and hydrochlorothiazide 10/12.5 as an original ANDA (with similar products 20/12.5 and 20/25) for th…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. [Phase 3]
Phase 3 trial comparing azilsartan medoxomil with valsartan and olmesartan in adults with essential hypertension; results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension [Phase 3]
A Phase 3 trial assessed the efficacy and safety of once-daily azilsartan medoxomil co-administered with amlodipine in adults with essential…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension [Phase 2]
This Phase 2 trial update reports safety and efficacy findings for azilsartan medoxomil in adults with mild to moderate hypertension, with r…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil in African American adults with essential hypertension. The study i…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of azilsartan medoxomil co-administered with chlorthalidone in adults with essential hypert…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension [Phase 3]
A Phase 3 trial comparing azilsartan medoxomil to valsartan in adults with essential hypertension assessed efficacy and safety; results were…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension [Phase 3]
A Phase 3 trial comparing azilsartan medoxomil to ramipril for essential hypertension evaluated efficacy and safety; the study results were …
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension [Phase 3]
This Phase 3 clinical trial update reports one-year safety and tolerability results for azilsartan medoxomil in adults with essential hypert…
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: Sympathetic Nervous System Modulation in Hypertension [Phase 4]
Phase 4 trial on sympathetic nervous system modulation for hypertension was terminated; results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction [Phase 4]
This report indicates completion of a Phase 4 correlation study assessing vascular parameters in hypertensive men with erectile dysfunction.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension [Phase 3]
A Phase 3 trial evaluating irbesartan combined with hydrochlorothiazide as first-line therapy for severe hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-15Clinical Trial Update: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension [Phase 3]
Phase 3 clinical trial update for the irbesartan/hydrochlorothiazide fixed-dose combination in moderate hypertension; the study has complete…
-
CLINICAL_TRIALS other · 2011-04-15Clinical Trial Update: Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome [Phase 4]
Phase 4 trial update shows completion of an irbesartan study in hypertensive patients with metabolic syndrome. The update does not provide t…
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study
An observational study evaluating Telmisartan 80 mg combined with hydrochlorothiazide 25 mg for hypertension; results were posted in 2011. S…